My bookmarksSign up free

Council Decision (EU) 2021/764 CHAPTER I — General provisions

Article 1–Article 5 · 5 articles

Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Subject matter

Article 1

This Decision establishes the Specific Programme implementing Horizon Europe – the Framework Programme for Research and Innovation (the 'Specific Programme'), as set out in point (a) of Article 1(2) of Regulation (EU) 2021/695. This Decision lays down the operational objectives of the Specific Programme, the budget for the period 2021-2027, the rules for implementation of the Specific Programme and the activities to be carried out under the Specific Programme.

Operational objectives

Article 2

1.   The Specific Programme shall contribute to the general and specific objectives set out in Article 3 of Regulation (EU) 2021/695. 2.   The operational objectives of the Specific Programme are the following: (a) to strengthen excellent basic and frontier research; to reinforce and spread excellence, including by fostering wider participation throughout the Union; (b) to reinforce the link between research, innovation, and, where appropriate, education and other policies, including complementarities with national, regional and Union R&I policies and activities; (c) to support the implementation of Union policy priorities including in particular the SDGs and the Paris Agreement; (d) to promote responsible R&I, taking into account the precautionary principle; (e) to strengthen the gender dimension across the Specific Programme; (f) to increase collaboration links in European R&I and across sectors and disciplines, including social sciences and humanities (SSH); (g) to strengthen international cooperation; (h) to connect to and develop research infrastructures across the European Research Area (ERA) and to provide transnational access; (i) to attract talent, to train and retain researchers and innovators in the ERA, including through mobility; (j) to foster open science and ensure visibility to the public and open access to scientific publications and research data, including appropriate exceptions; (k) to encourage exploitation of R&I results and actively disseminate and exploit results, in particular for leveraging private investments and policy development; (l) to deliver, through R&I missions, on ambitious goals within a set timeframe; (m) to improve the relationship and interaction between science and society, including the visibility of science in society and science communication, and to promote the involvement of citizens and end-users in co-design and co-creation processes; (n) to accelerate industrial transformation, including through improved skills for innovation; (o) to stimulate R&I activities in SMEs and the creation and scale-up of innovative companies, in particular start-ups, SMEs, and in exceptional cases small mid-caps; (p) to improve access to risk finance, including through synergies with the InvestEU Programme established by Regulation (EU) 2021/523 of the European Parliament and of the Council  ( 11 ) , in particular where the market does not provide viable financing. 3.   In pursuing the objectives referred to in paragraph 2, account may be taken of new and unforeseen needs that arise during the period of implementation of the Specific Programme. That may, if duly justified, include responses to emerging opportunities, crises and threats, as well as responses to needs relating to the development of new Union policies.

Structure

Article 3

1.   Under Article 4(1) of Regulation (EU) 2021/695, the Specific Programme consists of the following parts: (a) Pillar I 'Excellent Science', with the following components: (i) the European Research Council (ERC), as described in Annex I, Pillar I, section 1; (ii) Marie Skłodowska-Curie Actions (MSCA), as described in Annex I, Pillar I, section 2; (iii) 'Research Infrastructures', as described in Annex I, Pillar I, section 3; (b) Pillar II 'Global Challenges and European Industrial Competitiveness', with the following components: (i) cluster 'Health', as described in Annex I, Pillar II, section 1; (ii) cluster 'Culture, Creativity and Inclusive Society', as described in Annex I, Pillar II, section 2; (iii) cluster 'Civil Security for Society', as described in Annex I, Pillar II, section 3; (iv) cluster 'Digital, Industry and Space', as described in Annex I, Pillar II, section 4; (v) cluster 'Climate, Energy and Mobility', as described in Annex I, Pillar II, section 5; (vi) cluster 'Food, Bioeconomy, Natural Resources, Agriculture and Environment', as described in Annex I, Pillar II, section 6; (vii) non-nuclear direct actions of the JRC, as described in Annex I, Pillar II, section 7; (c) Pillar III 'Innovative Europe', with the following components: (i) the European Innovation Council (EIC), as described in Annex I, Pillar III, section 1; (ii) European innovation ecosystems, as described in Annex I, Pillar III, section 2; (d) Part 'Widening Participation and Strengthening the ERA' with the following components: (i) widening participation and spreading excellence, as described in Annex I, Part 'Strengthening the ERA', section 1; (ii) reforming and enhancing the European R&I system, as described in Annex I, Part 'Strengthening the ERA', section 2. 2.   The activities to be carried out under the parts referred to in paragraph 1 are described in Annex I.

Budget

Article 4

1.   In accordance with Article 12(1) of Regulation (EU) 2021/695, the financial envelope for the implementation of the Specific Programme for the period from 1 January 2021 to 31 December 2027 shall be EUR 83 397 000 000 in current prices. 2.   As a result of the programme specific adjustment provided for in Article 5 of Council Regulation (EU, Euratom) 2020/2093  ( 12 ) and in Annex II to Regulation (EU, Euratom) 2020/2093, the amount referred to in paragraph 1 shall be increased by an additional allocation of EUR 2 790 000 000 in constant 2018 prices for the Specific Programme. 3.   The amount referred to in paragraph 1 of this Article shall be distributed among the components set out in Article 3(1) of this Decision in accordance with Article 12(2) of Regulation (EU) 2021/695. The amount referred to in paragraph 2 of this Article shall be distributed among the components set out in Article 3(1) of this Decision in accordance with Article 12(4) of Regulation (EU) 2021/695. The arrangements set out in Article 12(5) to (9) of Regulation (EU) 2021/695 shall apply.

Resources from the European Union Recovery Instrument

Article 5

1.   In accordance with Article 13 of Regulation (EU) 2021/695 the measures referred to in Article 1(2) of Council Regulation (EU) 2020/2094  ( 13 ) shall be implemented under this Specific Programme through amounts referred to in point (a)(iv) of Article 2(2) of that Regulation, subject to its Article 3(3), (4), (7) and (9). Those additional amounts shall exclusively be allocated to actions for R&I directed at addressing the consequences of the COVID-19, in particular its economic, social and societal consequences. Priority shall be given to innovative SMEs and special attention shall be paid to their integration in collaborative projects under Pillar II 'Global Challenges and European Industrial Competitiveness'. 2.   The indicative distribution of the amount referred to in paragraph 1 shall be: (a) 25 % to cluster 'Health'; (b) 25 % to cluster 'Digital, Industry and Space'; (c) 25 % to cluster 'Climate, Energy and Mobility'; (d) 25 % to the EIC.

Back to Council Decision (EU) 2021/764 — full text

Articles on this page are reproduced verbatim from official open data. See the attribution line.

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

What to look at next